News Release

Boston University’s Dr. Emelia J. Benjamin named one of seven Distinguished Scientists

American Heart Association Scientific Sessions 2022

Grant and Award Announcement

American Heart Association

Embargoed until 7 a.m. CT / 8 a.m. ET Friday, Oct. 28, 2022

DALLAS, Oct. 28, 2022 – The American Heart Association is presenting one of its 2022 Distinguished Scientist awards to Emelia J. Benjamin, M.D., Sc.M., FAHA, of Boston University. The Association honors members who have significantly advanced the understanding of cardiovascular, stroke or brain health as Distinguished Scientists. Seven 2022 Distinguished Scientist awardees will be recognized during the Association’s Scientific Sessions 2022, which will be held in person in Chicago and virtually Nov. 5-7.

Dr. Benjamin’s research has thoroughly examined atrial fibrillation (AFib), the most common heart rhythm disturbance, which is associated with stroke, heart failure and death. Her work studied the epidemiology of AFib, as well as its risk factors and complications. Additionally, her research was among the first to demonstrate AFib — regardless of the presence of other cardiovascular disease and comorbidities — leads to increased mortality rates. Her work has been at the forefront of identifying risk factors for AFib, and it has influenced strategies to prevent the condition. Dr. Benjamin has co-led national workshops for the National Heart, Lung, and Blood Institute at the National Institutes of Health that identify priorities for the future of AFib research.

Dr. Benjamin is a Robert Dawson Evans Distinguished Professor of Medicine at Boston University’s Chobanian & Avedisian School of Medicine, a professor of Epidemiology at Boston University School of Public Health and an affiliate faculty member at Boston University Center for Antiracist Research. She also serves as the associate provost for faculty development at Boston University Medical Campus and as the vice chair of faculty development and diversity in the department of medicine at Boston University. Dr. Benjamin is also a board-certified attending cardiologist at Boston Medical Center. Additionally, at the Framingham Heart Study, she is the joint director of the medical endpoints review committee and a member of the research committee.

Dr. Benjamin earned a bachelor’s degree from Harvard University and a master’s degree in epidemiology from Harvard’s School of Public Health. She earned a Doctor of Medicine from Case Western Reserve University School of Medicine. Dr. Benjamin is a fellow of the Association’s Council on Epidemiology and Prevention, Clinical Cardiology Council, and Genomics and Precision Medicine Council.

She is a well-respected researcher, who is among the Clarivate List of Highly Cited Researchers (top 1%) from 2014-2022, having been cited more than 300,000 times (more than 150,000 times in just the past five years). She has published more than 650 original peer-reviewed articles and has mentored more than 50 early-stage investigators. She serves on the international editorial board of the European Heart Journal, the advisory board of Nature Reviews Cardiology and the editorial board of the Association’s Circulation.

Dr. Benjamin has served in numerous roles and has been recognized by the Association numerous times, including a 2019 Distinguished Achievement Award in Genomics and Precision Medicine, the 2016 Population Research Prize, the 2016 Gold Heart Award and the 2015 Paul Dudley White Award. She is also a past chair Association’s Functional Genomics and Translational Biology Council and Study Section, and the annual Heart and Stroke Statistical Update.

Additional Resources:

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here

The American Heart Association’s Scientific Sessions 2022 is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The 3-day meeting will feature more than 500 sessions focused on breakthrough cardiovascular basic, clinical and population science updates occurring Saturday through Monday, November 5-7, 2022. Thousands of leading physicians, scientists, cardiologists, advanced practice nurses and allied health care professionals from around the world will convene virtually to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to more than 4,000 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in Scientific Sessions 2022 on social media via #AHA22.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.orgFacebookTwitter or by calling 1-800-AHA-USA1.  


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.